What's new. News and updates from Ali Ramezani
Recent publications, conference talks, patent filings, and project milestones from the lab and the Nephrova and Medistant programs.
Passed the Ph.D. proposal defense
Successfully defended the doctoral research proposal at the University of Utah, advancing to Ph.D. candidacy in Biomedical Engineering.
U.S. provisional patent filed for hybrid optical-electrical connectors
“Hybrid Optical-Electrical Connectors with an Optical Coupling Medium” (Application 64/130,380) covers connector technology for biomedical sensing applications.
Bladder PuO₂ paper accepted for ANESTHESIOLOGY 2026
“Physics-Based Estimation of Bladder PuO₂ Improves AKI Discrimination After Cardiac Surgery” accepted for presentation at the ANESTHESIOLOGY® 2026 Annual Meeting in San Diego.
Diffusion-correction paper published in Scientific Reports
“Correcting Diffusion Artifacts in Urinary Oxygen Tension Monitoring” restores the diagnostic value of bedside urinary PO₂ by removing oxygen-diffusion artifacts.
Named an MIT Catalyst Fellow
Selected for MIT’s translational research program advancing high-impact healthcare technologies from concept toward clinical and commercial viability.
International PCT application filed for fluid transit-time tracking
“System and Method for Tracking Fluid Transit Time in a Conduit” (WO2026060269A1) extends the urinary-oxygen monitoring program toward commercial translation.
U.S. provisional patent filed: “Diffusion Adjusted Sensor System and Method”
Protecting the diffusion-correction method behind more trustworthy bedside urinary-oxygen monitoring.
Transit-time algorithm paper published in the Journal of Clinical Monitoring and Computing
An algorithm establishing sample validity so a bedside oxygen reading reflects the kidney rather than the tubing.